Overview
- 53 inspections across 50 sites are on record.
- 163 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-30.
At a glance
Inspections
53
Sites
50
Observations
163
Career since
Jul 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jilin Asymchem Pharmaceuticals Co., Ltd. | 30 Apr 2026 | Human Drugs | On file |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
| CHANGCHUN GENESCIENCE PHARMACEUTICAL CO.,LTD | 24 Apr 2026 | Human Drugs | On file |
| EUGIA Pharma Specialities Limited | 27 Feb 2026 | Human Drugs | On file |
| Shilpa Medicare Limited | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Jilin Asymchem Pharmaceuticals Co., Ltd.Dunhua, China1 insp.
Changchun GeneScience Pharmaceutical Co., Ltd.Changchun, China1 insp.
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO.,LTDChangchun, China1 insp.
EUGIA Pharma Specialities LimitedMedchal-Malkajgiri District, India1 insp.
Shilpa Medicare LimitedJadcherla, Mahabubnagar District, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Joohi Castelvetere4 shared
Sandra A Boyd3 shared
Eileen A Liu3 shared
Mary L Schuckmann3 shared
Gretchen L Trendel3 shared
Jacob G Lutz2 shared
Pratik S Upadhyay2 shared
Tamil Arasu2 shared
Rafeeq A Habeeb2 shared
Justin A Boyd2 shared
Full investigator report
Get the verbatim findings behind Joseph A Piechocki's 163 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site